ORCL Form 144 filing details planned 40,000-share sale via Fidelity
Rhea-AI Filing Summary
Oracle (ORCL) filed a Form 144 notice for a proposed sale of 40,000 common shares. The filing lists an aggregate market value of $11,065,506.10, with an approximate sale date of 10/21/2025 on the NYSE through Fidelity Brokerage Services LLC.
The shares to be sold were acquired via restricted stock vesting: 37,270 shares on 09/15/2025 and 2,730 shares on 09/19/2025. Shares outstanding are stated as 2,841,714,000. In the past three months, the person for whose account the sale is proposed sold 21,241 shares on 09/12/2025 for gross proceeds of $6,310,864.10.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Oracle (ORCL) disclose in this Form 144?
A proposed sale of 40,000 Oracle common shares with an aggregate market value of $11,065,506.10, planned around 10/21/2025 on the NYSE.
Which broker and exchange are listed for the proposed ORCL sale?
Broker: Fidelity Brokerage Services LLC; Exchange: NYSE.
Were there recent sales by the same ORCL affiliated person?
Yes. 21,241 shares were sold on 09/12/2025 for gross proceeds of $6,310,864.10.
What is the approximate sale date in the ORCL Form 144?
The approximate date of sale is 10/21/2025.